Taken together, these results suggest that −16kb enhancer of Fgf23 mediates the early onset of CKD‐induced increase in bone, thymus, and kidney Fgf23 transcription but that this upregulation contributes only partially to changes in circulating iFGF23 levels. Here, FGF23 is linked to chronic kidney disease.